 | • レポートコード：QYR9ST12872 • 出版社/出版日：QYResearch / 2019年9月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、カルムスチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、100mg注射、125mg注射に、用途別には、神経膠腫、多形性膠芽腫、髄芽腫および星状細胞腫、多発性骨髄腫、リンパ腫、その他にセグメント区分し、カルムスチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・カルムスチンの世界市場概要 ・カルムスチンの製造コスト構成分析 ・カルムスチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・カルムスチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・カルムスチンのセグメント分析（種類別） （100mg注射、125mg注射） ・カルムスチンのセグメント分析（用途別） （神経膠腫、多形性膠芽腫、髄芽腫および星状細胞腫、多発性骨髄腫、リンパ腫、その他） ・カルムスチンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Amneal Pharms、Arbor Pharms、Emcure Pharms、Navinta、STI Pharma、Obvius Pharmaceuticals、MGI Pharma、Marcan Pharmaceuticals、Eisai、Bristol-Myers Squibb、Pharmaplan、Sanli Ilac、Zydus Pharmaceuticals 、Tianjin Kingyork） ・カルムスチンの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Carmustine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Carmustine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Carmustine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Carmustine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Carmustine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Amneal Pharms
Arbor Pharms
Emcure Pharms
Navinta
STI Pharma
Obvius Pharmaceuticals
MGI Pharma
Marcan Pharmaceuticals
Eisai
Bristol-Myers Squibb
Pharmaplan
Sanli Ilac
Zydus Pharmaceuticals
Tianjin Kingyork
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
100mg Injection
125mg Injection
Segment by Application
Glioma
Glioblastoma Multiforme
Medulloblastoma and Astrocytoma
Multiple Myeloma
Lymphoma
Other
Table of Contents
Executive Summary
1 Industry Overview of Carmustine
1.1 Definition of Carmustine
1.2 Carmustine Segment by Type
1.2.1 Global Carmustine Production Growth Rate Comparison by Types (2014-2025)
1.2.2 100mg Injection
1.2.3 125mg Injection
1.3 Carmustine Segment by Applications
1.3.1 Global Carmustine Consumption Comparison by Applications (2014-2025)
1.3.2 Glioma
1.3.3 Glioblastoma Multiforme
1.3.4 Medulloblastoma and Astrocytoma
1.3.5 Multiple Myeloma
1.3.6 Lymphoma
1.3.7 Other
1.4 Global Carmustine Overall Market
1.4.1 Global Carmustine Revenue (2014-2025)
1.4.2 Global Carmustine Production (2014-2025)
1.4.3 North America Carmustine Status and Prospect (2014-2025)
1.4.4 Europe Carmustine Status and Prospect (2014-2025)
1.4.5 China Carmustine Status and Prospect (2014-2025)
1.4.6 Japan Carmustine Status and Prospect (2014-2025)
1.4.7 Southeast Asia Carmustine Status and Prospect (2014-2025)
1.4.8 India Carmustine Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Carmustine
2.3 Manufacturing Process Analysis of Carmustine
2.4 Industry Chain Structure of Carmustine
3 Development and Manufacturing Plants Analysis of Carmustine
3.1 Capacity and Commercial Production Date
3.2 Global Carmustine Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Carmustine
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Carmustine Production and Capacity Analysis
4.2 Carmustine Revenue Analysis
4.3 Carmustine Price Analysis
4.4 Market Concentration Degree
5 Carmustine Regional Market Analysis
5.1 Carmustine Production by Regions
5.1.1 Global Carmustine Production by Regions
5.1.2 Global Carmustine Revenue by Regions
5.2 Carmustine Consumption by Regions
5.3 North America Carmustine Market Analysis
5.3.1 North America Carmustine Production
5.3.2 North America Carmustine Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Carmustine Import and Export
5.4 Europe Carmustine Market Analysis
5.4.1 Europe Carmustine Production
5.4.2 Europe Carmustine Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Carmustine Import and Export
5.5 China Carmustine Market Analysis
5.5.1 China Carmustine Production
5.5.2 China Carmustine Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Carmustine Import and Export
5.6 Japan Carmustine Market Analysis
5.6.1 Japan Carmustine Production
5.6.2 Japan Carmustine Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Carmustine Import and Export
5.7 Southeast Asia Carmustine Market Analysis
5.7.1 Southeast Asia Carmustine Production
5.7.2 Southeast Asia Carmustine Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Carmustine Import and Export
5.8 India Carmustine Market Analysis
5.8.1 India Carmustine Production
5.8.2 India Carmustine Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Carmustine Import and Export
6 Carmustine Segment Market Analysis (by Type)
6.1 Global Carmustine Production by Type
6.2 Global Carmustine Revenue by Type
6.3 Carmustine Price by Type
7 Carmustine Segment Market Analysis (by Application)
7.1 Global Carmustine Consumption by Application
7.2 Global Carmustine Consumption Market Share by Application (2014-2019)
8 Carmustine Major Manufacturers Analysis
8.1 Amneal Pharms
8.1.1 Amneal Pharms Carmustine Production Sites and Area Served
8.1.2 Amneal Pharms Product Introduction, Application and Specification
8.1.3 Amneal Pharms Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Arbor Pharms
8.2.1 Arbor Pharms Carmustine Production Sites and Area Served
8.2.2 Arbor Pharms Product Introduction, Application and Specification
8.2.3 Arbor Pharms Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Emcure Pharms
8.3.1 Emcure Pharms Carmustine Production Sites and Area Served
8.3.2 Emcure Pharms Product Introduction, Application and Specification
8.3.3 Emcure Pharms Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Navinta
8.4.1 Navinta Carmustine Production Sites and Area Served
8.4.2 Navinta Product Introduction, Application and Specification
8.4.3 Navinta Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 STI Pharma
8.5.1 STI Pharma Carmustine Production Sites and Area Served
8.5.2 STI Pharma Product Introduction, Application and Specification
8.5.3 STI Pharma Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Obvius Pharmaceuticals
8.6.1 Obvius Pharmaceuticals Carmustine Production Sites and Area Served
8.6.2 Obvius Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Obvius Pharmaceuticals Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 MGI Pharma
8.7.1 MGI Pharma Carmustine Production Sites and Area Served
8.7.2 MGI Pharma Product Introduction, Application and Specification
8.7.3 MGI Pharma Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Marcan Pharmaceuticals
8.8.1 Marcan Pharmaceuticals Carmustine Production Sites and Area Served
8.8.2 Marcan Pharmaceuticals Product Introduction, Application and Specification
8.8.3 Marcan Pharmaceuticals Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Eisai
8.9.1 Eisai Carmustine Production Sites and Area Served
8.9.2 Eisai Product Introduction, Application and Specification
8.9.3 Eisai Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Bristol-Myers Squibb
8.10.1 Bristol-Myers Squibb Carmustine Production Sites and Area Served
8.10.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.10.3 Bristol-Myers Squibb Carmustine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Pharmaplan
8.12 Sanli Ilac
8.13 Zydus Pharmaceuticals
8.14 Tianjin Kingyork
9 Development Trend of Analysis of Carmustine Market
9.1 Global Carmustine Market Trend Analysis
9.1.1 Global Carmustine Market Size (Volume and Value) Forecast 2019-2025
9.2 Carmustine Regional Market Trend
9.2.1 North America Carmustine Forecast 2019-2025
9.2.2 Europe Carmustine Forecast 2019-2025
9.2.3 China Carmustine Forecast 2019-2025
9.2.4 Japan Carmustine Forecast 2019-2025
9.2.5 Southeast Asia Carmustine Forecast 2019-2025
9.2.6 India Carmustine Forecast 2019-2025
9.3 Carmustine Market Trend (Product Type)
9.4 Carmustine Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Carmustine Distributors List
10.3 Carmustine Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Carmustine
Table Global Carmustine Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Carmustine Production Market Share by Types in 2018
Figure 100mg Injection Product Picture
Figure 125mg Injection Product Picture
Table Global Carmustine Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Carmustine Consumption Market Share by Applications in 2018
Figure Glioma
Figure Glioblastoma Multiforme
Figure Medulloblastoma and Astrocytoma
Figure Multiple Myeloma
Figure Lymphoma
Figure Other
Figure Global Carmustine Revenue (Million USD) (2014-2025)
Figure Global Carmustine Production (K Pcs) (2014-2025)
Figure North America Carmustine Market Size (Million USD) (2014-2025)
Figure Europe Carmustine Market Size (Million USD) (2014-2025)
Figure China Carmustine Market Size (Million USD) (2014-2025)
Figure Japan Carmustine Market Size (Million USD) (2014-2025)
Figure Southeast Asia Carmustine Market Size (Million USD) (2014-2025)
Figure India Carmustine Market Size (Million USD) (2014-2025)
Table Carmustine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Carmustine in 2018
Figure Manufacturing Process Analysis of Carmustine
Figure Industry Chain Structure of Carmustine
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Carmustine Manufacturing Plants Distribution
Table Carmustine Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Carmustine Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Carmustine Production (K Pcs) of Major Manufacturers (2014-2019)
Table Carmustine Production Market Share of Major Manufacturers (2014-2019)
Figure Carmustine Production Share by Manufacturers in 2018
Table Carmustine Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Carmustine Revenue Market Share of Major Manufacturers (2014-2019)
Figure Carmustine Revenue Share by Manufacturers in 2018
Table Carmustine Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Carmustine Production by Regions 2014-2019 (K Pcs)
Table Global Carmustine Production Market Share by Regions 2014-2019
Figure Global Carmustine Production Market Share by Regions in 2018
Table Global Carmustine Revenue by Regions 2014-2019 (Million USD)
Table Global Carmustine Revenue Market Share by Regions 2014-2019
Figure Global Carmustine Revenue Market Share by Regions in 2018
Table Global Carmustine Consumption by Regions 2014-2019 (K Pcs)
Table Global Carmustine Consumption Market Share by Regions 2014-2019
Figure North America Carmustine Production Growth Rate 2014-2019 (K Pcs)
Figure North America Carmustine Revenue Growth Rate 2014-2019 (Million USD)
Table North America Carmustine Production, Consumption Import and Export (K Pcs)
Figure Europe Carmustine Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Carmustine Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Carmustine Production, Consumption Import and Export (K Pcs)
Figure China Carmustine Production Growth Rate 2014-2019 (K Pcs)
Figure China Carmustine Revenue Growth Rate 2014-2019 (Million USD)
Table China Carmustine Production, Consumption Import and Export (K Pcs)
Figure Japan Carmustine Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Carmustine Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Carmustine Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Carmustine Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Carmustine Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Carmustine Production, Consumption Import and Export (K Pcs)
Figure India Carmustine Production Growth Rate 2014-2019 (K Pcs)
Figure India Carmustine Revenue Growth Rate 2014-2019 (Million USD)
Table India Carmustine Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Carmustine Market Share by Application (2014-2019)
Figure Global Value (Consumption) Carmustine Market Share by Application (2014-2019)
Table Amneal Pharms Carmustine Production Sites and Area Served
Table Amneal Pharms Carmustine Product Introduction, Application and Specification
Table Amneal Pharms Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amneal Pharms Carmustine Production Growth Rate (2014-2019)
Table Amneal Pharms Carmustine Production Market Share (2014-2019)
Figure Amneal Pharms Carmustine Revenue Market Share (2014-2019)
Table Amneal Pharms Carmustine Main Business and Markets Served
Table Arbor Pharms Carmustine Production Sites and Area Served
Table Arbor Pharms Carmustine Product Introduction, Application and Specification
Table Arbor Pharms Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Arbor Pharms Carmustine Production Growth Rate (2014-2019)
Table Arbor Pharms Carmustine Production Market Share (2014-2019)
Figure Arbor Pharms Carmustine Revenue Market Share (2014-2019)
Table Arbor Pharms Carmustine Main Business and Markets Served
Table Emcure Pharms Carmustine Production Sites and Area Served
Table Emcure Pharms Carmustine Product Introduction, Application and Specification
Table Emcure Pharms Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Emcure Pharms Carmustine Production Growth Rate (2014-2019)
Table Emcure Pharms Carmustine Production Market Share (2014-2019)
Figure Emcure Pharms Carmustine Revenue Market Share (2014-2019)
Table Emcure Pharms Carmustine Main Business and Markets Served
Table Navinta Carmustine Production Sites and Area Served
Table Navinta Carmustine Product Introduction, Application and Specification
Table Navinta Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Navinta Carmustine Production Growth Rate (2014-2019)
Table Navinta Carmustine Production Market Share (2014-2019)
Figure Navinta Carmustine Revenue Market Share (2014-2019)
Table Navinta Carmustine Main Business and Markets Served
Table STI Pharma Carmustine Production Sites and Area Served
Table STI Pharma Carmustine Product Introduction, Application and Specification
Table STI Pharma Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table STI Pharma Carmustine Production Growth Rate (2014-2019)
Table STI Pharma Carmustine Production Market Share (2014-2019)
Figure STI Pharma Carmustine Revenue Market Share (2014-2019)
Table STI Pharma Carmustine Main Business and Markets Served
Table Obvius Pharmaceuticals Carmustine Production Sites and Area Served
Table Obvius Pharmaceuticals Carmustine Product Introduction, Application and Specification
Table Obvius Pharmaceuticals Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Obvius Pharmaceuticals Carmustine Production Growth Rate (2014-2019)
Table Obvius Pharmaceuticals Carmustine Production Market Share (2014-2019)
Figure Obvius Pharmaceuticals Carmustine Revenue Market Share (2014-2019)
Table Obvius Pharmaceuticals Carmustine Main Business and Markets Served
Table MGI Pharma Carmustine Production Sites and Area Served
Table MGI Pharma Carmustine Product Introduction, Application and Specification
Table MGI Pharma Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MGI Pharma Carmustine Production Growth Rate (2014-2019)
Table MGI Pharma Carmustine Production Market Share (2014-2019)
Figure MGI Pharma Carmustine Revenue Market Share (2014-2019)
Table MGI Pharma Carmustine Main Business and Markets Served
Table Marcan Pharmaceuticals Carmustine Production Sites and Area Served
Table Marcan Pharmaceuticals Carmustine Product Introduction, Application and Specification
Table Marcan Pharmaceuticals Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Marcan Pharmaceuticals Carmustine Production Growth Rate (2014-2019)
Table Marcan Pharmaceuticals Carmustine Production Market Share (2014-2019)
Figure Marcan Pharmaceuticals Carmustine Revenue Market Share (2014-2019)
Table Marcan Pharmaceuticals Carmustine Main Business and Markets Served
Table Eisai Carmustine Production Sites and Area Served
Table Eisai Carmustine Product Introduction, Application and Specification
Table Eisai Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Carmustine Production Growth Rate (2014-2019)
Table Eisai Carmustine Production Market Share (2014-2019)
Figure Eisai Carmustine Revenue Market Share (2014-2019)
Table Eisai Carmustine Main Business and Markets Served
Table Bristol-Myers Squibb Carmustine Production Sites and Area Served
Table Bristol-Myers Squibb Carmustine Product Introduction, Application and Specification
Table Bristol-Myers Squibb Carmustine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Carmustine Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Carmustine Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Carmustine Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Carmustine Main Business and Markets Served
Table Pharmaplan Carmustine Production Sites and Area Served
Table Sanli Ilac Carmustine Production Sites and Area Served
Table Zydus Pharmaceuticals Carmustine Production Sites and Area Served
Table Tianjin Kingyork Carmustine Production Sites and Area Served
Figure Global Carmustine Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Carmustine Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Carmustine Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Carmustine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Carmustine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Carmustine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Carmustine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Carmustine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Carmustine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Carmustine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Carmustine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Carmustine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Carmustine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Carmustine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Carmustine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Carmustine by Type (2019-2025)
Table Global Consumption (K Pcs) of Carmustine by Application (2019-2025)
Table Carmustine Distributors List
Table Carmustine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測 Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. In 2018, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx milli…- 再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測 Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. In 2018, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx milli…
- 多発性骨髄腫用るCAR T細胞療法の世界市場：市場規模・現状・予測 CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 多発性骨髄腫治療の世界市場：市場規模・現状・予測 Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma i…
- 多発性骨髄腫診断の世界市場：市場規模・現状・予測 Plasma cells help in fighting infection however, malignant plasma cells in multiple myeloma accumulate in the bone marrow, blocks the normal function of plasma cells. The M protein which is an abnormal antibody produced by malignant plasma cells cause tumors, bone destruction, kidney damage, and dam…